Valproate inhibits methamphetamine induced hyperactivity via glycogen synthase kinase 3β signaling in the nucleus accumbens core

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Xing, Bo ^a,b   Liang, Xiao Ping ^b   Liu, Peng ^a   Zhao, Yan ^a,c   Chu, Zheng ^a   Dang, Yong Hui ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Xi'an Mental Health Center   (China)

^c XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; METHAMPHETAMINE; VALPROIC ACID; CENTRAL STIMULANT AGENT; GLYCOGEN SYNTHASE KINASE 3; GSK3B PROTEIN, RAT; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HISTOLOGY; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; HYPERKINESIS; METABOLISM; MICROINJECTION; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HYPERKINESIS; MALE; METHAMPHETAMINE; MICROINJECTIONS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SERINE; SIGNAL TRANSDUCTION; VALPROIC ACID;

EID: 84935001008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128068     Document Type: Article

References (45)

1. Goodwin FK, Jamison KR (2007) Manic-depressive illness: bipolar disorders and recurrent depression: Oxford University Press.
2. Machado-Vieira R, Kapczinski F, Soares JC (2004) Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 28:209-224. PMID: 14751416
3. Fibiger H (1991) The dopamine hypotheses of schizophrenia and mood disorders: contradictions and speculations. The mesolimbic dopamine system: From motivation to action 615. PMID: 12742253
4. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16:223-244. PMID: 1665095
5. Mylecharane EJ (1996) Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies. Behav Brain Res 73:1-5. PMID: 8788468
6. Kim WY, Kim S, Kim JH (2008) Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity. Neurosci Lett 432:54-57. doi: 10.1016/j.neulet. 2007.12.005 PMID: 18164815
7. Heimer L, Alheid GF, De Olmos JS, Groenewegen HJ, Haber SN, Harlan RE, et al. (1997) The accumbens: beyond the core-shell dichotomy. J Neuropsychiatry Clin Neurosci 9:354-381. PMID: 9276840
8. Embi N, Rylatt DB, Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107:519-527. PMID: 6249596
9. Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9:2431-2438. PMID: 2164470
10. Takahashi M, Tomizawa K, Kato R, Sato K, Uchida T, Fujita SC, et al. (1994) Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J Neurochem 63:245-255. PMID: 7515946
11. Leroy K, Brion JP (1999) Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat 16:279-293. PMID: 10450875
12. Eldar-Finkelman H (2002) Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 8:126-132. PMID: 11879773
13. Bhat RV, Budd Haeberlein SL, Avila J (2004) Glycogen synthase kinase 3: a drug target for CNS therapies. J Neurochem 89:1313-1317. PMID: 15189333
14. Li YC, Gao WJ (2011) GSK-3beta activity and hyperdopamine-dependent behaviors. Neurosci Biobehav Rev 35:645-654. doi: 10.1016/j.neubiorev. 2010.08.001 PMID: 20727368
15. Miller JS, Tallarida RJ, Unterwald EM (2009) Cocaine-induced hyperactivity and sensitization are dependent on GSK3. Neuropharmacology 56:1116-1123. doi: 10.1016/j.neuropharm.2009.03.006 PMID: 19328817
16. Xu CM, Wang J, Wu P, Zhu WL, Li QQ, Xue YX, et al. (2009) Glycogen synthase kinase 3beta in the nucleus accumbens core mediates cocaine-induced behavioral sensitization. J Neurochem 111:1357-1368. doi: 10.1111/j.1471-4159.2009.06414.x PMID: 19799712
17. Enman NM, Unterwald EM (2012) Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse. Behav Brain Res 231:217-225. PMID: 22649795
18. Miller JS, Barr JL, Harper LJ, Poole RL, Gould TJ, Unterwald EM, et al. (2014) The GSK3 signaling pathway is activated by cocaine and is critical for cocaine conditioned reward in mice. PLoS One 9:e88026. doi: 10.1371/journal.pone.0088026 PMID: 24505362
19. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, et al. (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 101:5099-5104. PMID: 15044694
20. Bossert JM, Gray SM, Lu L, Shaham Y (2006) Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology 31:2197-2209. PMID: 16341024
21. PAXINOS G and WATSON C (1986) The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic.
22. Xing B, Zhao Y, Zhang H, Dang Y, Chen T, Huang J, et al. (2011) Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antidepressant-like effect in the rat forced swim test. Brain Res Bull 85:153-157. doi: 10.1016/j.brainresbull.2011.03.007 PMID: 21419831
23. Zhao Y, Xing B, Dang YH, Qu CL, Zhu F, Yan CX. (2013) Microinjection of valproic acid into the ventrolateral orbital cortex enhances stress-related memory formation. PLoS One 8:e52698. doi: 10.1371/journal.pone.0052698 PMID: 23300985
24. Xing B, Liu P, Xu WJ, Xu FY, Dang YH (2014) Effect of microinjecting of 5-aza-2-deoxycytidine into ventrolateral orbital cortex on depressive-like behavior in rats. Neurosci Lett 574:11-14. doi: 10.1016/j.neulet.2014.04.050 PMID: 24813108
25. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225. PMID: 9457173
26. Greengard P (2001) The neurobiology of slow synaptic transmission. Science 294:1024-1030. PMID: 11691979
27. Urs NM, Snyder JC, Jacobsen JP, Peterson SM, Caron MG (2012) Deletion of GSK3beta in D2R-expressing neurons reveals distinct roles for beta-arrestin signaling in antipsychotic and lithium action. Proc Natl Acad Sci U S A 109:20732-20737. doi: 10.1073/pnas.1215489109 PMID: 23188793
28. Xu CM, Wang J, Wu P, Xue YX, Zhu WL, Li QQ, et al. (2011) Glycogen synthase kinase 3beta in the nucleus accumbens core is critical for methamphetamine-induced behavioral sensitization. J Neurochem 118:126-139. doi: 10.1111/j.1471-4159.2011.07281.x PMID: 21517846
29. Bassareo V, De Luca MA, Di Chiara G (2002) Differential Expression of Motivational Stimulus Properties by Dopamine in Nucleus Accumbens Shell versus Core and Prefrontal Cortex. J Neurosci 22:4709-4719. PMID: 12040078
30. Di Chiara G (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 137:75-114. PMID: 12445717
31. Lobo MK, Covington HE 3rd, Chaudhury D, Friedman AK, Sun H, Damez-Werno D, et al. (2010) Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330:385-390. doi: 10.1126/science.1188472 PMID: 20947769
32. Ito R, Hayen A (2011) Opposing roles of nucleus accumbens core and shell dopamine in the modulation of limbic information processing. J Neurosci 31:6001-6007. doi: 10.1523/JNEUROSCI.6588-10. 2011 PMID: 21508225
33. Cacciapaglia F, Saddoris MP, Wightman RM, Carelli RM (2012) Differential dopamine release dynamics in the nucleus accumbens core and shell track distinct aspects of goal-directed behavior for sucrose. Neuropharmacology 62:2050-2056. doi: 10.1016/j.neuropharm.2011.12.027 PMID: 22261383
34. Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A 92:12304-12308. PMID: 8618890
35. Westerink BH (1995) Brain microdialysis and its application for the study of animal behaviour. Behav Brain Res 70:103-124. PMID: 8561902
36. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, et al. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 Suppl 1:227-241. PMID: 15464140
37. Zhu LQ, Wang SH, Liu D, Yin YY, Tian Q, Wang XC, et al. (2007) Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J Neurosci 27:12211-12220. PMID: 17989287
38. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, et al. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53:703-717. PMID: 17329210
39. Nelson CD, Kim MJ, Hsin H, Chen Y, Sheng M (2013) Phosphorylation of threonine-19 of PSD-95 by GSK-3beta is required for PSD-95 mobilization and long-term depression. J Neurosci 33:12122-12135. doi: 10.1523/JNEUROSCI.0131-13.2013 PMID: 23864697
40. Li JX, Han R, Deng YP, Chen SQ, Liang JH (2005) Different effects of valproate on methamphetamineand cocaine-induced behavioral sensitization in mice. Behav Brain Res 161:125-132. PMID: 15904719
41. Owens MJ, Nemeroff CB (2003) Pharmacology of valproate. Psychopharmacol Bull 37 Suppl 2:17-24. PMID: 14624230
42. Agmo A, Belzung C, Giordano M (1996) Interactions between dopamine and GABA in the control of ambulatory activity. J Neural Transm 103:925-934. PMID: 9013386
43. Cott J, Engel J (1977) Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems. J Neural Transm 40:253-268. PMID: 18553
44. Sandoval MR, Palermo-Neto J (1995) Effect of manipulation of the GABA system on dopamine-related behaviors. Braz J Med Biol Res 28:88-99. PMID: 7581034
45. Lu FF, Su P, Liu F, Daskalakis ZJ (2012) Activation of GABA (B) receptors inhibits protein kinase B/glycogen synthase kinase 3 signaling. Mol Brain 5:41. doi: 10.1186/1756-6606-5-41 PMID: 23192081